Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. [electronic resource]
- Hepatobiliary & pancreatic diseases international : HBPD INT Jun 2012
- 278-84 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't